Annexin A5 (ANXA5)

ANX5; ENX2; PP4; PAP-I; CBP-I; Anchorin CII; Calphobindin I; Endonexin II; Lipocortin V; Placental anticoagulant protein 4; Thromboplastin inhibitor; Vascular anticoagulant-alpha

SPN	W499
HGNC	543
MGI	106008
PubMed	17406257
RGD	2120
UniProt	P08758
Wiki	ANXA5

(or annexin V) is a cellular protein in the annexin group. The function of the protein is unknown, however annexin A5 has been proposed to play a role in the inhibition of blood coagulation by competing for phosphatidylserine binding sites with prothrombin and also to inhibit the activity of phospholipase A1. These properties have been found by in vitro experiments. Antibodies directed against annexin A5 are the cause of a syndrome called the antiphospholipid syndrome. Annexin A5 is used as a probe in the annexin A5 affinity assay to detect cells that have expressed phosphatidylserine on the cell surface, a feature found in apoptosis as well as other forms of cell death. Platelets also expose phosphatidylserine on their surface when activated, which serves as binding site for various coagulation factors.

Reference

"Primary structure of human placental anticoagulant protein."
Biochemistry 26:8087-8092(1987) [PubMed] [Europe PMC] [Abstract]

"Structure and expression of cDNA for an inhibitor of blood coagulation isolated from human placenta: a new lipocortin-like protein."
J. Biochem. 102:1261-1273(1987) [PubMed] [Europe PMC] [Abstract]

"Cloning and expression of cDNA for human vascular anticoagulant, a Ca2+-dependent phospholipid-binding protein."
Eur. J. Biochem. 174:585-592(1988) [PubMed] [Europe PMC] [Abstract]

"Cloning and expression of cDNA for human endonexin II, a Ca2+ and phospholipid binding protein."
J. Biol. Chem. 263:8037-8043(1988) [PubMed] [Europe PMC] [Abstract]

"Five distinct calcium and phospholipid binding proteins share homology with lipocortin I."
J. Biol. Chem. 263:10799-10811(1988) [PubMed] [Europe PMC] [Abstract]

"Characterization of cDNA encoding human placental anticoagulant protein (PP4): homology with the lipocortin family."
Proc. Natl. Acad. Sci. U.S.A. 85:3708-3712(1988) [PubMed] [Europe PMC] [Abstract]

"The gene encoding human annexin V has a TATA-less promoter with a high G+C content."
Gene 149:253-260(1994) [PubMed] [Europe PMC] [Abstract]

"Organization of the human annexin V (ANX5) gene."
Genomics 20:463-467(1994) [PubMed] [Europe PMC] [Abstract]

"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Nat. Genet. 36:40-45(2004) [PubMed] [Europe PMC] [Abstract]

"Generation and annotation of the DNA sequences of human chromosomes 2 and 4."
Nature 434:724-731(2005) [PubMed] [Europe PMC] [Abstract]

"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]

"A 32 kDa lipocortin from human mononuclear cells appears to be identical with the placental inhibitor of blood coagulation."
Biochem. J. 263:929-935(1989) [PubMed] [Europe PMC] [Abstract]

, Submitted (JAN-2005) to UniProtKB

"Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein."
Virology 197:549-557(1993) [PubMed] [Europe PMC] [Abstract]

"Structural and functional characterization of endonexin II, a calcium- and phospholipid-binding protein."
Proc. Natl. Acad. Sci. U.S.A. 84:6078-6082(1987) [PubMed] [Europe PMC] [Abstract]

"Sedimentation equilibrium analysis of five lipocortin-related phospholipase A2 inhibitors from human placenta. Evidence against a mechanistically relevant association between enzyme and inhibitor."
J. Biol. Chem. 263:18657-18663(1988) [PubMed] [Europe PMC] [Abstract]

"Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes."
Biochem. J. 383:237-248(2004) [PubMed] [Europe PMC] [Abstract]

"Substrate and functional diversity of lysine acetylation revealed by a proteomics survey."
Mol. Cell 23:607-618(2006) [PubMed] [Europe PMC] [Abstract]

"A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss."
Hum. Mol. Genet. 16:573-578(2007) [PubMed] [Europe PMC] [Abstract]

"Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach."
Anal. Chem. 81:4493-4501(2009) [PubMed] [Europe PMC] [Abstract]

"Lysine acetylation targets protein complexes and co-regulates major cellular functions."
Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract]

"Initial characterization of the human central proteome."
BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]

"Target-selective protein S-nitrosylation by sequence motif recognition."
Cell 159:623-634(2014) [PubMed] [Europe PMC] [Abstract]

"An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome."
J. Proteomics 96:253-262(2014) [PubMed] [Europe PMC] [Abstract]

"The crystal and molecular structure of human annexin V, an anticoagulant protein that binds to calcium and membranes."
EMBO J. 9:3867-3874(1990) [PubMed] [Europe PMC] [Abstract]

"The calcium binding sites in human annexin V by crystal structure analysis at 2.0-A resolution. Implications for membrane binding and calcium channel activity."
FEBS Lett. 275:15-21(1990) [PubMed] [Europe PMC] [Abstract]

"Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins."
J. Mol. Biol. 223:683-704(1992) [PubMed] [Europe PMC] [Abstract]

"Crystal structure of annexin V with its ligand K-201 as a calcium channel activity inhibitor."
J. Mol. Biol. 274:16-20(1997) [PubMed] [Europe PMC] [Abstract]

"Residue-specific bioincorporation of non-natural, biologically active amino acids into proteins as possible drug carriers: structure and stability of the per-thiaproline mutant of annexin V."
Proc. Natl. Acad. Sci. U.S.A. 95:455-459(1998) [PubMed] [Europe PMC] [Abstract]